US officials find new drugs tied to meningitis outbreak
US health officials identified two new drugs which may have infected patients with meningitis as they investigate a widening outbreak tied to tainted products from a Massachusetts pharmacy.
US health officials identified two new drugs which may have infected patients with meningitis as they investigate a widening outbreak tied to tainted products from a Massachusetts pharmacy.
Two more drugs from a US pharmaceutical firm may be linked to an outbreak of meningitis that has killed 15 people, officials warn.
CHICAGO/NEW YORK (Reuters) – Two other drugs made by the Massachusetts pharmacy at the center of a deadly meningitis outbreak may be linked to the disease, U.S. health regulators said on Monday, potentially widening the scope of the health crisis. The …
CHICAGO/NEW YORK (Reuters) – Two other drugs made by the Massachusetts pharmacy at the center of a deadly meningitis outbreak may be linked to the disease, U.S. health regulators said on Monday, potentially widening the scope of the health crisis. The …
LAWRENCE, Mass., Oct. 12, 2012 /PRNewswire/ — NxStage® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, will participate in the National Kidney Foundation (NKF) New …
The University of Texas at Austin on Monday unveiled a new laboratory that officials say will fill a critical gap to develop new drugs and biotechnology products.
A young Ontario father who suffers from kidney disease and needs a transplant has found out the drug benefits he lost because his wife is collecting employment insurance while on maternity leave will be restored.
A novel therapy in the early stages of development shows promise in providing lasting protection against the progression of multiple myeloma following a stem cell transplant by making the cancer cells easier targets for the immune system.
Kim Gabriel visits with Dart at Health First Holmes Regional Medical Center in Melbourne. / Tim Shortt/FLORIDA TODAY Kim Gabriel, 54, has been awaiting a heart transplant after complications from open-heart surgery in 2011 severely damaged her heart.
Orgenesis Inc. , a development-stage company with a novel therapeutic technology dedicated to converting a patient’s own liver cells int